Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
222
天
Arylpiperazine Derivative NAF19 Inhibits Prostate Cancer Activity and Its Molecular Mechanisms
作者
Hua Jiang; Mingzhen Xu; Songsong Jiang; Weiqiang Huang展开收起
作者单位
1. Department of Urology, The Fifth Affiliated Hospital of Zunyi Medical University (Zhuhai Sixth People’s Hospital), Zhuhai, China; 2. The Department of Biological and Pharmaceutical Sciences, Zhuhai Campus of Zunyi Medical University, Zhuhai, China展开收起
100
天
Treatment Outcomes with Lanadelumab Every 2 Weeks and Garadacimab are Very Similar in Patients with Hereditary Angioedema
作者
Irmgard Andresen; Natalie Khutoryansky; Sarah L. Feeny; Alissa Dangel展开收起
作者单位
1. Takeda Pharmaceuticals International AG, Zurich, Switzerland; 2. Takeda Development Center Americas, Inc., Lexington, USA; 3. Takeda Pharmaceuticals USA, Inc., Cambridge, USA展开收起
314
天
The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies
作者
HeeJae Choi; Shilpa Madari; Elmar Daalman; Brett A. English; Atef Halabi; Kathrin Hohl; Yury Shatillo; Nathalie Weidinger; Michael Desch展开收起
作者单位
1. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, USA; 2. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany; 3. CRS Clinical Research Services Kiel GmbH, Kiel, Germany展开收起
187
天
Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood–Brain Barrier
作者
Yicong Lei; Tingyu Xiao; Xin Hu; Huaqing Lin展开收起
作者单位
1. Key laboratory for Advanced Drug Delivery Systems of Guangdong Province, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天